COVID-19 Impact on Global Ophthalmol Drug, Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Ophthalmol Drug Product Introduction
• 1.2 Market Segments
• 1.3 Key Ophthalmol Drug Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Ophthalmol Drug Market Size Growth Rate by Type
  • 1.4.2 Retinal disorders drugs
  • 1.4.3 Allergic, inflammatory and infective drugs
  • 1.4.4 Glaucoma drugs
  • 1.4.5 Dry eye drugs
• 1.5 Market by Application
  • 1.5.1 Global Ophthalmol Drug Market Size Growth Rate by Application
  • 1.5.2 Glaucoma
  • 1.5.3 Dry eye syndrome
  • 1.5.4 Retinal diseases
  • 1.5.5 Other ophthalmic indications
• 1.6 Coronavirus Disease 2019 (Covid-19): Ophthalmol Drug Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Ophthalmol Drug Industry
    • 1.6.1.1 Ophthalmol Drug Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Ophthalmol Drug Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Ophthalmol Drug Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Ophthalmol Drug Market Size Estimates and Forecasts
  • 2.1.1 Global Ophthalmol Drug Revenue 2015-2026
  • 2.1.2 Global Ophthalmol Drug Sales 2015-2026
• 2.2 Ophthalmol Drug Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ophthalmol Drug Competitor Landscape by Players

• 3.1 Ophthalmol Drug Sales by Manufacturers
  • 3.1.1 Ophthalmol Drug Sales by Manufacturers (2015-2020)
  • 3.1.2 Ophthalmol Drug Sales Market Share by Manufacturers (2015-2020)
• 3.2 Ophthalmol Drug Revenue by Manufacturers
  • 3.2.1 Ophthalmol Drug Revenue by Manufacturers (2015-2020)
  • 3.2.2 Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Ophthalmol Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Ophthalmol Drug Revenue in 2019
  • 3.2.5 Global Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Ophthalmol Drug Price by Manufacturers
• 3.4 Ophthalmol Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Ophthalmol Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Ophthalmol Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Ophthalmol Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Ophthalmol Drug Market Size by Type (2015-2020)
  • 4.1.1 Global Ophthalmol Drug Sales by Type (2015-2020)
  • 4.1.2 Global Ophthalmol Drug Revenue by Type (2015-2020)
  • 4.1.3 Ophthalmol Drug Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Ophthalmol Drug Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Ophthalmol Drug Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Ophthalmol Drug Revenue Forecast by Type (2021-2026)
  • 4.2.3 Ophthalmol Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Ophthalmol Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Ophthalmol Drug Market Size by Application (2015-2020)
  • 5.1.1 Global Ophthalmol Drug Sales by Application (2015-2020)
  • 5.1.2 Global Ophthalmol Drug Revenue by Application (2015-2020)
  • 5.1.3 Ophthalmol Drug Price by Application (2015-2020)
• 5.2 Ophthalmol Drug Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Ophthalmol Drug Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Ophthalmol Drug Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Ophthalmol Drug Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Ophthalmol Drug by Country
  • 6.1.1 North America Ophthalmol Drug Sales by Country
  • 6.1.2 North America Ophthalmol Drug Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Ophthalmol Drug Market Facts & Figures by Type
• 6.3 North America Ophthalmol Drug Market Facts & Figures by Application

7 Europe

• 7.1 Europe Ophthalmol Drug by Country
  • 7.1.1 Europe Ophthalmol Drug Sales by Country
  • 7.1.2 Europe Ophthalmol Drug Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Ophthalmol Drug Market Facts & Figures by Type
• 7.3 Europe Ophthalmol Drug Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Ophthalmol Drug by Region
  • 8.1.1 Asia Pacific Ophthalmol Drug Sales by Region
  • 8.1.2 Asia Pacific Ophthalmol Drug Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Ophthalmol Drug Market Facts & Figures by Type
• 8.3 Asia Pacific Ophthalmol Drug Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Ophthalmol Drug by Country
  • 9.1.1 Latin America Ophthalmol Drug Sales by Country
  • 9.1.2 Latin America Ophthalmol Drug Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Ophthalmol Drug Market Facts & Figures by Type
• 9.3 Central & South America Ophthalmol Drug Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Ophthalmol Drug by Country
  • 10.1.1 Middle East and Africa Ophthalmol Drug Sales by Country
  • 10.1.2 Middle East and Africa Ophthalmol Drug Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Type
• 10.3 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Application

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Corporation Information
  • 11.1.2 Novartis Description, Business Overview and Total Revenue
  • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Novartis Ophthalmol Drug Products Offered
  • 11.1.5 Novartis Recent Development
• 11.2 Allergan
  • 11.2.1 Allergan Corporation Information
  • 11.2.2 Allergan Description, Business Overview and Total Revenue
  • 11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Allergan Ophthalmol Drug Products Offered
  • 11.2.5 Allergan Recent Development
• 11.3 Roche
  • 11.3.1 Roche Corporation Information
  • 11.3.2 Roche Description, Business Overview and Total Revenue
  • 11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Roche Ophthalmol Drug Products Offered
  • 11.3.5 Roche Recent Development
• 11.4 Valeant
  • 11.4.1 Valeant Corporation Information
  • 11.4.2 Valeant Description, Business Overview and Total Revenue
  • 11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Valeant Ophthalmol Drug Products Offered
  • 11.4.5 Valeant Recent Development
• 11.5 Regeneron
  • 11.5.1 Regeneron Corporation Information
  • 11.5.2 Regeneron Description, Business Overview and Total Revenue
  • 11.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Regeneron Ophthalmol Drug Products Offered
  • 11.5.5 Regeneron Recent Development
• 11.6 Santen
  • 11.6.1 Santen Corporation Information
  • 11.6.2 Santen Description, Business Overview and Total Revenue
  • 11.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Santen Ophthalmol Drug Products Offered
  • 11.6.5 Santen Recent Development
• 11.7 Bayer
  • 11.7.1 Bayer Corporation Information
  • 11.7.2 Bayer Description, Business Overview and Total Revenue
  • 11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Bayer Ophthalmol Drug Products Offered
  • 11.7.5 Bayer Recent Development
• 11.8 Pfizer
  • 11.8.1 Pfizer Corporation Information
  • 11.8.2 Pfizer Description, Business Overview and Total Revenue
  • 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Pfizer Ophthalmol Drug Products Offered
  • 11.8.5 Pfizer Recent Development
• 11.9 Senju
  • 11.9.1 Senju Corporation Information
  • 11.9.2 Senju Description, Business Overview and Total Revenue
  • 11.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Senju Ophthalmol Drug Products Offered
  • 11.9.5 Senju Recent Development
• 11.10 Akorn
  • 11.10.1 Akorn Corporation Information
  • 11.10.2 Akorn Description, Business Overview and Total Revenue
  • 11.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Akorn Ophthalmol Drug Products Offered
  • 11.10.5 Akorn Recent Development
• 11.1 Novartis
  • 11.1.1 Novartis Corporation Information
  • 11.1.2 Novartis Description, Business Overview and Total Revenue
  • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Novartis Ophthalmol Drug Products Offered
  • 11.1.5 Novartis Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Ophthalmol Drug Market Estimates and Projections by Region
  • 12.1.1 Global Ophthalmol Drug Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Ophthalmol Drug Revenue Forecast by Regions 2021-2026
• 12.2 North America Ophthalmol Drug Market Size Forecast (2021-2026)
  • 12.2.1 North America: Ophthalmol Drug Sales Forecast (2021-2026)
  • 12.2.2 North America: Ophthalmol Drug Revenue Forecast (2021-2026)
  • 12.2.3 North America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
• 12.3 Europe Ophthalmol Drug Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Ophthalmol Drug Sales Forecast (2021-2026)
  • 12.3.2 Europe: Ophthalmol Drug Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Ophthalmol Drug Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Ophthalmol Drug Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Ophthalmol Drug Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Ophthalmol Drug Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Ophthalmol Drug Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Ophthalmol Drug Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Ophthalmol Drug Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Ophthalmol Drug Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Ophthalmol Drug Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Ophthalmol Drug Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Ophthalmol Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Ophthalmol Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Ophthalmol Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source